XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements Of Changes In Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Capital Surplus
Capital Surplus
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive (Loss) Income
Accumulated Other Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning balance at Dec. 31, 2020     $ 701,106   $ 47,619   $ 171,304     $ 589,988   $ (139,038)   $ 31,233
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Net income $ 88,080     $ 0   $ 0   $ 88,080     $ 0   $ 0  
Other comprehensive loss, net of tax (16,973)     0   0   0     0   (16,973)  
Cash dividends declared (36,242)     0   0   (36,242)     0   0  
Stock-based compensation expense, net 3,121         3,121                
Restricted awards granted $ 0     0   (1,860)   0     1,860   0  
Exercise of stock options 15,000                          
Exercise of stock options $ 691     0   (1,623)   0     2,314   0  
Purchase of treasury shares (58,678)                   (58,678)      
Ending balance at Dec. 31, 2021 681,105     47,619   170,942   641,826     (193,542)   14,260  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture       0       0     0   0  
Treasury Stock, Value, Acquired, Cost Method       0       0         0  
Net income 102,071     0   0   102,071     0   0  
Other comprehensive loss, net of tax (145,748)     0   0   0     0   (145,748)  
Cash dividends declared (37,201)     0   0   (37,201)     0   0  
Stock-based compensation expense, net 3,276         3,276                
Restricted awards granted $ 0     0   (2,821)   0     2,821   0  
Exercise of stock options 15,000                          
Exercise of stock options $ 798     0   (417)   0     1,215   0  
Purchase of treasury shares (26,449)                   (26,449)      
Ending balance at Dec. 31, 2022 577,852     47,619   170,980   706,696     (215,955)   (131,488)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture       0       0     0   0  
Treasury Stock, Value, Acquired, Cost Method       0   0   0         0  
Net income 114,365     0   0   114,365     0   0  
Other comprehensive loss, net of tax 20,949     0   0   0     0   20,949  
Cash dividends declared (40,937)     0   0   (40,937)     0   0  
Stock-based compensation expense, net 3,213         3,213                
Restricted awards granted $ 0     0   (3,848)   0     3,848   0  
Exercise of stock options 0                          
Purchase of treasury shares $ (60,134)                   (60,134)      
Stock Issued During Period, Value, Acquisitions 61,583     0   7,079   0     54,504   0  
Ending balance at Dec. 31, 2023 $ 677,066 $ 175 $ 578,027 47,619 $ 47,619 177,424 $ 170,980 780,299 $ 175 $ 706,871 (217,737) $ (215,955) (110,539) $ (131,488)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                            
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture       0       0     $ 0   0  
Treasury Stock, Value, Acquired, Cost Method       $ 0   $ 0   $ 0         $ 0